News | News By Subject | News by Disease News By Date | Search News

News By Date

Get Our FREE
Industry eNewsletter
email:    
News By Date

SuMoTuWeThFrSa
2930311234
567891011
12131415161718
19202122232425
2627281234
567891011

Friday, February 24, 2017

Top Breaking News

News from Around the Web
This Bay Area Anti-Aging Drug Company Is Secretly Preparing For Trump's New FDA
Drug Giants Like AbbVie (ABBV), Bristol-Myers Squibb (BMY) and Gilead (GILD) Turn to Well-Known Professors to Justify Its Outrageous Drug Prices
Vertex (VRTX)'s Headcount Hits a New Four-Year High in 2016
Why 2017 Will be a Data-Rich and Not Revenue-Focused Year for bluebird bio (BLUE)
A Secret No More: New York Biotech Incubator Plots Its Growth
Growing Threat Could Kill 10 Million People A Year By 2050
4 Large Cap Biotechs To Stock Up On
Will BACE Inhibitors Help Alzheimer's Patients?
Could Prolonged Sleep Be An Early Warning Sign Of Dementia? Boston University School of Medicine Reveals
Ex-Valeant (VRX) and Philidor Execs Plead Not Guilty in Fraud Scheme
French Medtech Visiomed Group (VSG) Opens Up Small Office in Boston With Plans to Hire in 2018
Senators Introduce A Bill To Overhaul Medical Device Inspections
Fitbit (FIT): Turnaround Story Or Falling Knife?
New Technique For Cheaper, More Efficient Single Cell Sequencing, Oregon Health & Science University (OHSU) Study Reveals
Nano Thread Enables Scientists To Extend Length Of Brain Implant Efficacy, University of Texas Study
Is Trump About To Blow Up Medtronic (MDT)'s Tax Avoidance Business Model?

Press Releases
Investors Breathe a Sigh of Relief Cempra (CEMP)'s Skin Infection Drug Hits Phase III Goals
Augmenix Release: Phase 3 Trial Data Show Use Of SpaceOAR Hydrogel Helps Maintain Erectile Function Following Prostate Cancer Radiation Treatment
Janssen-Cilag AG Release: DARZALEX (Daratumumab) Receives Positive CHMP Opinion For The Treatment Of Multiple Myeloma In Patients Who Have Received At Least One Prior Therapy
Auris Med (EARS) Receives FDA Fast Track Designation For AM-111 In Acute Sensorineural Hearing Loss
Nivalis (NVLS) Announces Results From Phase II Clinical Trial Of Cavosonstat Added To Ivacaftor For Treatment Of Cystic Fibrosis
Galapagos (GLPG.BR) Doses First Healthy Volunteer With CF Combo GLPG2222 And GLPG2451
Trillium Therapeutics Provides Additional Details On ASCO-SITC Conference Presentation On TTI-621
IntelliPharmaCeutics Announces FDA Approval For 500 Mg And 750 Mg Generic Glucophage XR
Celgene (CELG) Release: REVLIMID (Lenalidomide) Approved By European Commission (EC) As Monotherapy For The Maintenance Treatment Of Patients With Newly Diagnosed Multiple Myeloma After Autologous Stem Cell Transplantation
Dipharma Announces The Validation Of Disanit (Nitisinone) Marketing Authorization Application In Europe
Symic Biomedical Announces Last Patient Enrolled In SHIELD Trial Of SB-030 For Interventions In Peripheral Artery Disease
Corbus (CRBP) Announces Preclinical Data Demonstrating JBT-101 Reduces Inflammation In Alveolar Macrophages From Cystic Fibrosis Patients
Real-World Data From Boehringer Ingelheim Show Lower Risk Of Stroke And Major Bleeding For Pradaxa (Dabigatran Etexilate Mesylate) Compared To Warfarin
Experimental Biology and Medicine Release: Targeting Chemokine Signaling To Overcome Radiation Resistance In Colorectal Cancer
Xynomic Pharma Has Acquired Worldwide Rights Of Abexinostat
ANI Pharma Acquires Inderal XL And InnoPran XL
Antibe Therapeutics (ATE.V) Enters Into Regional Licensing Deal
Fudan-Zhangjiang Bio-Pharma Invests $2 Million In Adgero Of The U.S.
Caladrius Biosciences (CLBS) Awarded $12.2 Million Grant From CIRM In Support Of Phase II Clinical Trial Of CLBS03 To Treat Type 1 Diabetes
Qilu Pharma Launches Biosimilar To AstraZeneca PLC (AZN)'s Iressa In China
DMD Therapeutics Receives Funding From DMD Foundations To Develop DMD-813 For Treatment Of Duchenne Muscular Dystrophy
Provectus Provides Information On Rights Offering Deadline
Karolinska Development AB Notes Oncopeptides' Successful Listing On Nasdaq Stockholm - Company's Earn-Out Has A Current Market Value Of SEK 26.7 Million
QuintilesIMS (Q) Announces Pricing Of Senior Notes
Heron (HRTX) Announces Inclusion Of SUSTOL (Granisetron) Extended-Release Injection In NCCN Antiemesis Guidelines
Swiss Specialty Pharma Company Santhera (SANN.SW) Announces Opening Of U.S. Office In Burlington, MA
CryoPort Launches The "CoBRA Index" For A Comprehensive Measure Of Activity In The Regenerative Therapy Space
Alimera Sciences (ALIM) To Report Fourth Quarter 2016 Financial Results On March 1, 2017
Achillion (ACHN) Reports 2016 Fourth Quarter And Year-End Financial Results
AcelRx (ACRX) To Hold Annual 2016 Financial Results Conference Call And Webcast On Thursday, March 2nd, 2017
ArQule (ARQL) To Report Fourth Quarter And Year End 2016 Financial Results On March 7, 2017
BioMarin (BMRN) Announces Fourth Quarter And Full Year 2016 Financial Results
Cannimed Reports Financial Results For 2016
China Biologic Products Reports Financial Results For The Fourth Quarter And Fiscal Year 2016
EyeGate Pharma Reports Full-Year 2016 Financial Results And Provides Business Update
Galapagos (GLPG.BR) Reports Strong Financial Results And Newsflow-Rich Pipeline
Heron (HRTX) Announces Fourth Quarter And Full Year 2016 Financial Results And Recent Corporate Progress
Karolinska Development AB - Q4 And 2016 Year-End Report - Invitation To Conference Call And Webcast
Ligand (LGND) Reports Fourth Quarter And Full Year 2016 Financial Results
La Jolla Pharma (LJPC) Announces Fourth Quarter And Full Year 2016 Financial Results And Corporate Progress
Nevro (NVRO) Reports Fourth Quarter And Full Year 2016 Financial Results And Provides 2017 Outlook
Otonomy (OTIC) To Report Fourth Quarter And Full Year 2016 Financial Results And Provide Corporate Update
OvaScience (OVAS) To Host Fourth Quarter And Fiscal Year 2016 Financial Results Conference Call
PharMerica Reports Fourth Quarter And Full Year 2016 Results
Parnell Pharmaceuticals Holdings To Report Financial Results For Fiscal Year 2016 On March 22, 2017
Regulus (RGLS) To Release Fourth Quarter And Full Year 2016 Financial Results On March 2, 2017
RedHill Biopharma (RDHL) Reports 2016 Fourth Quarter And Full-Year Financial Results
Radius Health (RDUS) Reports Fourth Quarter And Full Year 2016 Financial And Operating Results
Sucampo (SCMP) Announces Fourth Quarter And Full Year 2016 Earnings Call
Pulmonary Fibrosis Foundation President And Ceo, Dr. Patti Tuomey, Departs For Education Role
Achaogen (AKAO) Announces Leadership Promotions
Medivir (MVRBF)'s Nomination Committee Proposes New Board Of Directors Ahead Of 2017 AGM
Ronald E. Blaylock Elected To Pfizer (PFE)’s Board Of Directors
Ironwood (IRWD) To Host R&D Day On March 9, 2017
Fitbit (FIT): Turnaround Story Or Falling Knife?
Headwall Sets Up Shop in Boston, Plans to Hire
New Technique For Cheaper, More Efficient Single Cell Sequencing, Oregon Health & Science University (OHSU) Study Reveals
Nano Thread Enables Scientists To Extend Length Of Brain Implant Efficacy, University of Texas Study
Is Trump About To Blow Up Medtronic (MDT)'s Tax Avoidance Business Model?
Xenex Locks in $38 Million in Funding
Bay Area's Intersect ENT Grabs FDA Approval of Newest Steroid Releasing Implant, PROPEL Contour
LivaNova PLC (LIVN) to Exit the London Stock Exchange
bioMerieux: FDA Clears Test To Help Manage Antibiotic Treatment For Lower Respiratory Tract Infections And Sepsis
E-QURE's BST Device For Chronic Wound Care Receives Marketing Approval In Israel
Annidis CEO Resigns Less Than One Year on the Job, Effective Immediately
Medtronic (MDT) Receives CE Mark For Its Next Generation Cardiac Resynchronization Therapy-Pacemakers
VolitionRX's Triage Test Results Validated In Prospective Trial
NYU Langone Medical Center Release: New Assay May Lead To A Cure For Debilitating Inflammatory Joint Disease
CureMatch Announces New Advances In Using Metabolomic Profiling To Distinguish Among Cancer Subtypes
Medtronic (MDT) New Solitaire Stent Retriever Study Validates Outcomes And Real-World Application Of Stroke Treatment Best Practices
LabCorp (LH) To Acquire Pathology Associates Medical Laboratories From Providence Health & Services And Catholic Health Initiatives
Evidation Health And Shepherd Center Join Forces To Measure Real-Life Experiences Of People With Neurological Conditions
Paragon 28 Announces The Launch Of First Aseptically Processed Hammertoe Allograft-PRESERVE HammerGraft System
Aeon Global Health Launches BDx Advantage- Extensive Blood Diagnostic Testing
Abiomed (ABMD) Surpasses 50,000 Impella® Patients Treated In The United States
Monaghan Medical 's Drug-Free Aerobika Device Helps Reduce The Real-World Impact Of Exacerbations In Chronic Obstructive Pulmonary Disease
InstantLabs Secures Controlling Investment From Angeon Group
Medifirst Solutions Updates Shareholders
SANUWAVE Launches "SHOCK THIS" Blog
Accelerate Diagnostics (AXDX) Receives FDA Marketing Authorization For The Accelerate Pheno System And Accelerate PhenoTest BC Kit
Nucleus Biologics Continues To Feed Scientific Breakthrough With Unprecedented Two-Year, Fixed-Price Guarantee On Premium Fetal Bovine Serum For Scientists
Bio-Rad (BIO) Reports Fourth-Quarter And Full-Year 2016 Financial Results
CytoSorbents To Report Fiscal 2016 Operating And Financial Results
Senseonics Reports Fourth Quarter 2016 Financial Results

//-->